Novel 3&prime-deoxy-3&prime-acylaminospectinomycin compounds are described. Also described are methods of using the 3&prime-deoxy-3-acylaminospectinomycin compounds and other spectinomycin analogs in treating tuberculosis and in treating microbial infections.